Clinical Trial Update: Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous iron in gynecologic cancer patients receiving chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Intravenous iron (unspecified formulation) (intravenous iron)

Snippet

Sponsor: Chulalongkorn University | Conditions: Gynecologic Cancer | Phase 3 | Status: COMPLETED